Scientists using a technology called cryo-EM (cryo-electron microscopy) have broken through a technological barrier in visualizing proteins with an approach that may have an impact on drug discovery and development. They were able to capture images of glutamate dehydrogenase, an enzyme found in cells, at a resolution of 1.8 angstroms, a level of detail at which the structure of the central parts of the enzyme could be visualized in atomic detail. The scientists from the National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues also reported achieving another major milestone, by showing that the shapes of cancer target proteins too small to be considered within the reach of current cryo-EM capabilities can now be determined at high resolution.
Related posts:
- Medicare Card, NIH study demonstrates that a new cancer immunotherapy method could be effective against a wide range of cancers A new method for using immunotherapy to specifically attack tumor cells that have mutations unique to a patient’s cancer has been developed by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. The researchers demonstrated that the human immune system can mount a response against mutant proteins expressed by cancers […]...
- Medicare Card, Major cancer protein amplifies global gene expression. Medicare Card, Major cancer protein amplifies global gene expression....
- NIH researchers link rare cancer to cell oxygen deficiency Researchers at the National Institutes of Health have discovered that a rare cancer of the digestive tract is linked to a shutdown in an enzyme that helps supply oxygen to cells....
- Medicare Future? Pathways that Can Repair Brca1 Cancer Gene Mutation Clarified in Mice In a new study in mice, scientists have compensated for mutations in the Brca1 gene that can lead to cancer by deleting a second gene, which then lessens the probability of cancer. Mice Brca1-associated mammary tumors have significant similarities to human BRCA1- associated (BReast CAncer 1, early onset) breast cancer in regard to tumor aggressiveness, high incidence, mutations and genetic instability. The study, led by scientists at National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues, appeared online April 1, 2010 and in print April 16, 2010, in the journal Cell....
- Medicare Card, NIH mouse study finds gut microorganisms may determine cancer treatment outcome An unhealthy gut microbiome may limit treatment effectiveness. An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, and their […]...
- Medicare Card: Gene Linked to Alzheimer’s Disease Plays Key Role in Cell Survival Scientists have discovered that a gene linked to Alzheimer’s disease may play a beneficial role in cell survival by enabling neurons to clear away toxic proteins. A study funded by the National Institute on Aging (NIA), part of the National Institutes of Health, shows the presenilin 1 (PS1) gene is essential to the function of […]...
- Medicare Card, Versatile proteins could be new target for Alzheimer’s drugs Medicare Card, Versatile proteins could be new target for Alzheimer's drugs...
- Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
- Medicare Card, NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer Medicare Card, NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer...
- Medicare Card, Compounds activate key cancer enzyme to interfere with tumor formation Medicare Card, Compounds activate key cancer enzyme to interfere with tumor formation...
- Medicare, study uncovers new mechanism of action for class of chemotherapy drugs National Institutes of Health (NIH) researchers have discovered a significant new mechanism of action for a class of chemotherapy drugs known as poly (ADP-ribose) polymerase inhibitors, or PARP inhibitors. They have also identified differences in the toxic capabilities of three drugs in this class which are currently being tested in clinical trials. The study, by […]...
- Medicare Card, Scientists develop genetic blueprint of inner ear cell development Medicare Card, Scientists develop genetic blueprint of inner ear cell development...
- Cigarette smoking implicated in half of bladder cancers in women Current cigarette smokers have a higher risk of bladder cancer than previously reported, and the risk in women is now comparable to that in men, according to a study by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health. The report was published on Aug. 16, 2011, in the Journal […]...
- The Cancer Genome Atlas completes detailed ovarian cancer analysis An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature. MedicareCard.com […]...
- Medicare Card, Study points to possible treatment for lethal pediatric brain cancer Medicare Card, Study points to possible treatment for lethal pediatric brain cancer...